Morphological Changes in Bone Marrow Post Imatinib Therapy in Chronic Phase CML: A Follow up Study on Sequential Bone Marrow Aspirates and Biopsies

Morphological Changes in Bone Marrow Post Imatinib Therapy in Chronic Phase CML: A Follow up Study on Sequential Bone Marrow Aspirates and Biopsies

Introduction: Imatinib mesylate is used extensively for first line treatment of Chronic Myeloid Leukemia (CML). However, not many studies have documented morphological changes in bone marrow biopsies produced during Imatinib therapy with reference to myelofibrosis. Aim: To document the morpholo...

Full description

Bibliographic Details
Main Authors: Neha Chopra Narang, Usha Rusia, Meera Sikka, Mrinalini Kotru
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2017-04-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
bone marrow morphology
imatinib mesylate
myelofibrosis
myeloproliferative neoplasms
philadelphia chromosome
Online Access:https://jcdr.net/articles/PDF/9650/25173_CE[Ra1]_F(GH)_PF1(P_P_SH)_PFA(NC)_PF2(P_SH).pdf

Internet

https://jcdr.net/articles/PDF/9650/25173_CE[Ra1]_F(GH)_PF1(P_P_SH)_PFA(NC)_PF2(P_SH).pdf

Similar Items